Utilization of real‐world data in assessing treatment effectiveness for diffuse large B‐cell lymphoma

por Nowakowski, Grzegorz, Maurer, Matthew J., Cerhan, James R., Dey, Debarshi, Sehn, Laurie H.
Publicado 2022

Matching-adjusted indirect comparison of the pelabresib-ruxolitinib combination vs JAKi monotherapy in myelofibrosis

por Gupta, Vikas, Mascarenhas, John, Kremyanskaya, Marina, Rampal, Raajit K., Talpaz, Moshe, Kiladjian, Jean-Jacques, Vannucchi, Alessandro M., Verstovsek, Srdan, Colak, Gozde, Dey, Debarshi, Harrison, Claire
Publicado 2023

RE-MIND: Comparing Tafasitamab + Lenalidomide (L-MIND) with a Real-world Lenalidomide Monotherapy Cohort in Relapsed or Refractory Diffuse Large B-cell Lymphoma

por Zinzani, Pier Luigi, Rodgers, Thomas, Marino, Dario, Frezzato, Maurizio, Barbui, Anna Maria, Castellino, Claudia, Meli, Erika, Fowler, Nathan H., Salles, Gilles, Feinberg, Bruce, Kurukulasuriya, Nuwan C., Tillmanns, Sascha, Parche, Stephan, Dey, Debarshi, Fingerle-Rowson, Günter, Ambarkhane, Sumeet, Winderlich, Mark, Nowakowski, Grzegorz S.
Publicado 2021